Clinical Trial Update: A Clinical Investigation of MINIVISC® PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F), Used for Cataract Surgery and Implantation of Intraocular Lenses, Glaucoma Surgery, Anterior Segment Surgery and Corneal Transplantation (CGAC) [NA]

View source ↗

Summary

A completed clinical trial investigating MINIVISC PLUS 14 mg/ml fermented ophthalmic viscosurgical device (OVD-F) for cataract surgery and related ocular proced…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• MINIVISC PLUS 14 mg/ml Fermented Ophthalmic Viscosurgical Device (OVD-F) (fermented ophthalmic viscosurgical device (OVD-F))

Snippet

Sponsor: Bohus Biotech AB | Conditions: Cataract | NA | Status: COMPLETED